Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Endevica Bio
1945 Techny Rd, Suite 14
Northbrook, IL 60062
Phone: 573-881-5080
https://endevicabio.com/

Endevica Bio creates first-in-class peptide drug candidates. Endevica's technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to modulate activity of G-protein coupled receptors behind the blood-brain barrier. Endevica's initial drug candidate, TCMCB07, is designed to treat cachexia, which is caused by many diseases like cancer, renal failure and congestive heart failure.

Key Contact
Name
Russell Potterfield
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/19/23 $10,000,000 Series B


Featured Reading